|
(V252) |
Impact of surgical valve size on invasive pressure gradients and hemodynamics in patients undergoing valve-in-valve transcatheter aortic valve implantation for degenerated surgical bioprostheses |
|
|
M. Okamoto, T. Yamanaka, M. Bannehr, A. Haase-Fielitz, F. Hölschermann, G. Tambor, M. Neuß, C. Butter (Bernau bei Berlin) |
|
|
Diskussion |
|
(V253) |
Impact of postoperative annular diameter on mid-term outcomes after aortic valve repair |
|
|
J. Petersen, T. Holst, S. Krohm, N. Neumann, C. Sinning, H. Reichenspurner, E. Girdauskas (Hamburg) |
|
|
Diskussion |
|
(V254) |
Early Hemodynamic Changes and In-Hospital Outcome after Transcatheter Aortic Valve Replacement in Patients with Severe Low Gradient Aortic Stenosis. |
|
|
J. Schewel, C. Frerker, M. Schlüter, T. Schmidt, M. Schmoeckel, K.-H. Kuck, D. Schewel (Hamburg) |
|
|
Diskussion |
|
(V255) |
Transvascular transcatheter aortic valve replacement in Germany in 2017 – latest development in complication rates |
|
|
L. Gaede, J. Blumenstein, W.-K. Kim, C. Liebetrau, O. Dörr, H. Nef, O. Husser, C. W. Hamm, A. Elsässer, S. Achenbach, H. Möllmann (Dortmund, Bad Nauheim, Gießen, Oldenburg, Erlangen) |
|
|
Diskussion |
|
(V256) |
Prediction of 30-day mortality after Transcatheter Aortic Valve Implantation using Neural Networks |
|
|
B. F. Gomes, M. Pilz, F. Leuschner, M. Konstandin, H. A. Katus, B. Meder (Heidelberg) |
|
|
Diskussion |
|
(V257) |
Impaired survival with non-severe aortic valve calcification in patients with paradoxical low-flow, low-gradient aortic stenosis after transcatheter aortic valve implantation (TAVI) |
|
|
U. Fischer-Rasokat, M. Renker, C. Liebetrau, S. Schmidt, H. Baumgarten, M. Weferling, A. Rolf, M. Doss, H. Möllmann, T. Walther, C. W. Hamm, W.-K. Kim (Bad Nauheim, Dortmund, Frankfurt am Main) |
|
|
Diskussion |
|
(V258) |
Hemodynamic valve dysfunction following transcatheter aortic valve implantation with latest generation balloon-expandable valves: prevalence and predictors of elevated transvalvular gradients |
|
|
T. Rheude, C. Pellegrini, T. Schuster, J. Michel, T. Trenkwalder, J. Wiebe, M. Rumpf, P. Mayr, W. Hengstenberg, C. Hengstenberg, S. Cassese, M. Kasel, A. Kastrati, H. Schunkert, O. Husser, M. Joner (München, Dortmund; Montreal, CA; Wien, AT) |
|
|
Diskussion |
|
(V259) |
CoreValve Evolut Pro vs. Evolut R: Fallkontrollierte Studie in Patienten mit hochgradig kalzifizierter Aortenklappenanatomie |
|
|
K. Piayda, K. Hellhammer, V. Veulemans, S. S. Afzal, I. Hennig, M. Makosch, A. Polzin, G. Antoch, R. Westenfeld, C. Jung, M. Kelm, T. Zeus (Düsseldorf) |
|
|
Diskussion |
|
(V260) |
Detailed analysis of circulating levels of crucial cardiac extracellular matrix biomarkers in patients undergoing transfemoral Transcatheter Aortic Valve Implantation |
|
|
L. Bäz, G. Dannberg, K. Grün, S. Möbius-Winkler, H. Ebelt, A. Lauten, C. Jung, A. Berndt, C. Schulze, M. Franz (Jena, Erfurt, Berlin, Düsseldorf) |
|
|
Diskussion |